Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 1
1995 1
1999 1
2003 1
2004 2
2005 3
2006 5
2007 11
2008 6
2009 5
2010 6
2011 8
2012 10
2013 19
2014 14
2015 16
2016 14
2017 17
2018 28
2019 39
2020 47
2021 40
2022 39
Text availability
Article attribute
Article type
Publication date

Search Results

299 results
Results by year
Filters applied: . Clear all
Page 1
Asian Organization for Crohn's and Colitis and Asia Pacific Association of Gastroenterology practice recommendations for medical management and monitoring of inflammatory bowel disease in Asia.
Ran Z, Wu K, Matsuoka K, Jeen YT, Wei SC, Ahuja V, Chen M, Hu PJ, Andoh A, Kim HJ, Yang SK, Watanabe M, Ng SC, Hibi T, Hilmi IN, Suzuki Y, Han DS, Leung WK, Sollano J, Ooi CJ, Qian J. Ran Z, et al. J Gastroenterol Hepatol. 2021 Mar;36(3):637-645. doi: 10.1111/jgh.15185. Epub 2020 Jul 29. J Gastroenterol Hepatol. 2021. PMID: 32672839 Review.
Endpoints for extraintestinal manifestations in inflammatory bowel disease trials: the EXTRA consensus from the International Organization for the Study of Inflammatory Bowel Diseases.
Guillo L, Abreu M, Panaccione R, Sandborn WJ, Azevedo VF, Gensler L, Moghaddam B, Ahuja V, Ali SA, Allez M, Ananthakrishnan AN, Bhattacharya A, Dubinsky M, Griffiths A, Hart A, Korelitz B, Kotze PG, Koutroubakis IE, Lakatos PL, Lindsay JO, Magro F, Mantzaris GJ, Ng SC, O'Morain C, Panés J, Parigi T, Ran Z, Rogler G, Rubin DT, Sachar DB, Siegmund B, Steinwurz F, Tysk C, Vavricka S, Verstraete SG, Brezin AP, Haemel AK, Dignass A, Sands BE, Danese S, Peyrin-Biroulet L. Guillo L, et al. Among authors: ran z. Lancet Gastroenterol Hepatol. 2022 Mar;7(3):254-261. doi: 10.1016/S2468-1253(21)00297-1. Epub 2022 Jan 17. Lancet Gastroenterol Hepatol. 2022. PMID: 35051383
Epithelial-mesenchymal transition in Crohn's disease.
Jiang H, Shen J, Ran Z. Jiang H, et al. Among authors: ran z. Mucosal Immunol. 2018 Mar;11(2):294-303. doi: 10.1038/mi.2017.107. Epub 2017 Dec 20. Mucosal Immunol. 2018. PMID: 29346350 Review.
Risankizumab as induction therapy for Crohn's disease: results from the phase 3 ADVANCE and MOTIVATE induction trials.
D'Haens G, Panaccione R, Baert F, Bossuyt P, Colombel JF, Danese S, Dubinsky M, Feagan BG, Hisamatsu T, Lim A, Lindsay JO, Loftus EV Jr, Panés J, Peyrin-Biroulet L, Ran Z, Rubin DT, Sandborn WJ, Schreiber S, Neimark E, Song A, Kligys K, Pang Y, Pivorunas V, Berg S, Duan WR, Huang B, Kalabic J, Liao X, Robinson A, Wallace K, Ferrante M. D'Haens G, et al. Among authors: ran z. Lancet. 2022 May 28;399(10340):2015-2030. doi: 10.1016/S0140-6736(22)00467-6. Lancet. 2022. PMID: 35644154 Clinical Trial.
Natural killer T cells and ulcerative colitis.
Lai LJ, Shen J, Ran ZH. Lai LJ, et al. Among authors: ran zh. Cell Immunol. 2019 Jan;335:1-5. doi: 10.1016/j.cellimm.2018.08.010. Epub 2018 Aug 18. Cell Immunol. 2019. PMID: 30638678 Review.
Exosome in intestinal mucosal immunity.
Xu AT, Lu JT, Ran ZH, Zheng Q. Xu AT, et al. Among authors: ran zh. J Gastroenterol Hepatol. 2016 Oct;31(10):1694-1699. doi: 10.1111/jgh.13413. J Gastroenterol Hepatol. 2016. PMID: 27061439 Review.
Primary lymphomas in the gastrointestinal tract.
Peng JC, Zhong L, Ran ZH. Peng JC, et al. Among authors: ran zh. J Dig Dis. 2015 Apr;16(4):169-76. doi: 10.1111/1751-2980.12234. J Dig Dis. 2015. PMID: 25678011 Review.
299 results